Goldman Sachs’s LifePoint Health, Inc. LPNT Stock Holding History

Goldman Sachs’s Portfolio LPNT Stock Details LPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,500	Closed	-$85K	–	7286
2016 Q4	$85K	Buy	+1,500	New	+$86.8K	﹤0.01%	6220
2016 Q3	–	Sell	-4,400	Closed	-$288K	–	7442
2016 Q2	$288K	Buy	4,400 +2,300	+110%	+$156K	﹤0.01%	5370
2016 Q1	$145K	Sell	2,100 -3,100	-60%	-$207K	﹤0.01%	5859
2015 Q4	$382K	Sell	5,200 -300	-5%	-$21.3K	﹤0.01%	5140
2015 Q3	$390K	Buy	5,500 +1,900	+53%	+$154K	﹤0.01%	5385
2015 Q2	$313K	Sell	3,600 -700	-16%	-$52.9K	﹤0.01%	5695
2015 Q1	$316K	Sell	4,300 -3,100	-42%	-$220K	﹤0.01%	5592
2014 Q4	$532K	Buy	7,400 +3,000	+68%	+$208K	﹤0.01%	5225
2014 Q3	$304K	Buy	+4,400	New	+$309K	﹤0.01%	5746

Other funds holding LPNT

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Goldman Sachs's LPNT Position: Q4 2018 in Review

Goldman Sachs sold out of LifePoint Health, Inc. (LPNT) in Q4 2018, closing a stake of 323,313 shares — an estimated $20.8M sold.

Goldman Sachs first reported a position in LPNT in Q2 2013 and held it in 22 quarters. The position peaked at $26.7M in Q1 2017. 3 funds tracked by Wall St. Rank hold LPNT as of Q4 2018.

Goldman Sachs reported no remaining LifePoint Health, Inc. position as of Q4 2018 after selling out during the quarter.
Goldman Sachs sold 323,313 LifePoint Health, Inc. shares in Q4 2018, an estimated $20.8M.
Goldman Sachs first reported a position in LifePoint Health, Inc. in Q2 2013 and held it in 22 quarters.
Goldman Sachs's LifePoint Health, Inc. position peaked at $26.7M in Q1 2017.
3 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2018.

Based on Goldman Sachs's 13F filing for Q4 2018, filed 14 Feb 2019.